Long-term therapeutic effects of voglibose, a potent intestinal alpha-glucosidase inhibitor, in spontaneous diabetic GK rats. (Q44298316)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

title

Long-term therapeutic effects of voglibose, a potent intestinal alpha-glucosidase inhibitor, in spontaneous diabetic GK rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

author name string

K Yasuda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

K Shimowada

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

M Uno

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

H Odaka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

N Shihara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

N Suzuki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

A Tamon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

K Nagashima

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

M Hosokawa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

K Tsuda

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Y Seino

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

Diabetes Research and Clinical Practice

17 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

page(s)

113-122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.

17 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Acute and chronic effects of hyperglycaemia on glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Effects of the carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Effect of an intestinal disaccharidase inhibitor (AO-128) on obesity and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Voglibose administration before the evening meal improves nocturnal hypoglycemia in insulin-dependent diabetic patients with intensive insulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Beneficial effect of long-term combined treatment with voglibose and pioglitazone on pancreatic islet function of genetically diabetic GK rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Inhibition of progressive reduction of islet beta-cell mass in spontaneously diabetic Goto-Kakizaki rats by alpha-glucosidase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Assay of intestinal disaccharidases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Ribonucleic acid isolated by cesium chloride centrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Rat Insulin Genes: Construction of Plasmids Containing the Coding Sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

A membrane-filter technique for the detection of complementary DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

The nucleotide sequence of the rat cytoplasmic β–actin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Immunochemical studies on the subunits of rabbit-intestinal sucrase-isomaltase complex

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Differentiation and maturation of cultured fetal rat jejunum

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Caco-2 cells cultured in serum-free medium as a model for the study of enterocytic differentiation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Differentiation status of rat enterocytes after intestinal adaptation to jejunoileal bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Antiobesity and antidiabetic actions of a new potent disaccharidase inhibitor in genetically obese-diabetic mice, KKA(y)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

Miglitol: assessment of its role in the treatment of patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2802%2900241-3

7 January 2021

10.1016/S0168-8227(02)00241-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12560160%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference